Larimar Therapeutics, Inc. (LRMR)
3.94
+0.12
(+3.14%)
USD |
NASDAQ |
Sep 01, 16:00
3.945
0.00 (0.00%)
After-Hours: 20:00
Larimar Therapeutics Price : 3.94 for Sept. 1, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 01, 2026 | 3.78 | 3.95 | 3.77 | 3.94 | 755350.0 |
| Aug 31, 2026 | 3.98 | 4.00 | 3.81 | 3.82 | 1.066M |
| Aug 28, 2026 | 4.03 | 4.08 | 3.98 | 4.01 | 641506.0 |
| Aug 27, 2026 | 4.16 | 4.16 | 4.02 | 4.05 | 673588.0 |
| Aug 26, 2026 | 4.14 | 4.18 | 4.02 | 4.17 | 702136.0 |
| Aug 25, 2026 | 4.08 | 4.235 | 4.08 | 4.16 | 1.082M |
| Aug 24, 2026 | 4.23 | 4.23 | 3.93 | 4.05 | 945555.0 |
| Aug 21, 2026 | 4.20 | 4.21 | 4.085 | 4.18 | 699420.0 |
| Aug 20, 2026 | 4.21 | 4.21 | 3.975 | 4.16 | 1.158M |
| Aug 19, 2026 | 4.19 | 4.34 | 4.17 | 4.25 | 1.232M |
| Aug 18, 2026 | 4.31 | 4.35 | 4.05 | 4.06 | 869634.0 |
| Aug 17, 2026 | 4.33 | 4.420 | 4.30 | 4.32 | 882800.0 |
| Aug 14, 2026 | 4.26 | 4.39 | 4.17 | 4.36 | 1.183M |
| Aug 13, 2026 | 4.38 | 4.465 | 4.23 | 4.27 | 1.503M |
| Aug 12, 2026 | 4.31 | 4.40 | 4.275 | 4.37 | 1.181M |
| Aug 11, 2026 | 4.04 | 4.385 | 4.02 | 4.31 | 1.656M |
| Aug 10, 2026 | 4.15 | 4.29 | 4.005 | 4.01 | 1.397M |
| Aug 07, 2026 | 4.24 | 4.28 | 4.08 | 4.16 | 631188.0 |
| Aug 06, 2026 | 4.19 | 4.31 | 4.14 | 4.20 | 759755.0 |
| Aug 05, 2026 | 4.11 | 4.29 | 4.075 | 4.10 | 1.281M |
| Aug 04, 2026 | 3.98 | 4.139 | 3.82 | 4.11 | 1.682M |
| Aug 03, 2026 | 3.83 | 4.00 | 3.74 | 3.98 | 793828.0 |
| Jul 31, 2026 | 3.82 | 3.86 | 3.715 | 3.82 | 1.059M |
| Jul 30, 2026 | 3.65 | 3.895 | 3.60 | 3.825 | 1.033M |
| Jul 29, 2026 | 3.81 | 3.895 | 3.615 | 3.63 | 1.795M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| SELLAS Life Sciences Group, Inc. | 13.22 |
| Marker Therapeutics, Inc. | 1.30 |
| Rezolute, Inc. | 4.50 |
| Krystal Biotech, Inc. | 363.84 |
| ACADIA Pharmaceuticals, Inc. | 28.89 |
Price Related Metrics
| PEG Ratio | -0.0736 |
| Price to Book Value | 3.229 |
| Earnings Yield | -50.33% |
| Market Cap | 411.27M |
| PEGY Ratio | -0.0736 |